About Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Low-dose Aspirin Linked to Lower Colorectal Cancer Death Risk

Font : A-A+

Highlights:
  • Low dose aspirin/baby aspirin lowers risk of colorectal cancer death
  • Baby aspirin inhibits platelet activation and lowers rate of metastasis
  • Colorectal cancer causes approximately 53,000 deaths last year

Regular use of baby aspirin (contains 81 milligrams of aspirin) prior to colorectal cancer (CRC) diagnosis reduces the risk of death from the disease, revealed a study led by Cedars-Sinai Cancer researchers. Long-term use of aspirin limits the spread of cancerous tumors pre-diagnosis of colorectal cancer.

While previous research has offered consistent evidence that low-dose aspirin use reduces colorectal cancer risk, key findings from the study, published in the peer-reviewed Journal of the National Cancer Institute, revealed that the use of baby aspirin prior to the diagnosis of non-metastatic CRC was associated with a lower rate of metastasis, or tumor spread.

Advertisement

Low-dose Aspirin Linked to Lower Colorectal Cancer Death Risk
Low-dose Aspirin Linked to Lower Colorectal Cancer Death Risk

Starting aspirin after a colorectal cancer diagnosis was not associated with as strong a benefit as pre-diagnosis use. The researchers similarly found that the use of non-aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen, acetaminophen and naproxen, failed to confer those benefits.

"More evidence is needed, but this association between baby aspirin and lower death rates is highly significant," said epidemiologist and lead study author Jane C. Figueiredo, PhD. "These findings may provide an inexpensive lifestyle option to people seeking to prevent colorectal cancer, or to improve their prognoses if they are diagnosed."
Advertisement

The American Cancer Society estimates that about 104,600 cases of colon cancer and 43,300 cases of rectal cancer were diagnosed in the U.S. in 2020. Treatment usually involves surgery to remove the cancer, and possibly radiation therapy and chemotherapy.

How Aspirin Works

Researchers believe that differences in the way the aspirin and non-aspirin NSAIDs work affect the medications' differing colorectal cancer survival outcomes.

Low-dose aspirin use irreversibly prevents blood cells called platelets from activating and producing the enzyme thromboxane A2, which allows them to clump together. Tumor cells can attach to these clumps of platelets and spread throughout the body.

"Aspirin inhibits platelet activation, which also could inhibit metastases," said Figueiredo, the director of Community and Population Health Research and an associate professor of Medicine at the Samuel Oschin Cancer Institute at Cedars-Sinai.

Aspirin blocks platelet activation for the life cycle of the platelet. While non-aspirin NSAIDs also inhibit platelet activation, they do not do so permanently, and this could be why a strong association between their use and reduced rates of metastatic disease was not found.

Randomized clinical trials have provided some evidence that non-aspirin NSAIDs may inhibit colorectal cancer tumor formation. However, their association with colorectal cancer-specific mortality has been investigated in only a handful of studies, and the findings have been conflicting.

"Previous studies have not really separated aspirin use from use of non-aspirin NSAIDS," said Figueiredo. "We sought to understand the relationship between aspirin and non-aspirin NSAIDS and mortality in colorectal cancer patients."

Study Details

The observational study conducted by Figueiredo and colleagues included data from more than 2,500 men and women enrolled in the American Cancer Society Cancer Prevention Study-II nutrition cohort. All shared information about their aspirin and non-aspirin NSAID use and all eventually were diagnosed with colorectal cancer.

Researchers tracked participants' outcomes from their time of enrollment in 1992 or 1993 through December 2016. While the study did show that participants who began regular aspirin use after their diagnosis had better outcomes than those who did not use aspirin at all, the benefit was not clear enough to be called significant.

Figueiredo said that ongoing clinical trials are examining the impact of aspirin use, before and after diagnosis, on colorectal cancer mortality. When completed, they will provide additional guidance for physicians recommending treatments for their patients. "We have to wait until those results come out," Figueiredo said.

"There are potential harms associated with aspirin use," said Figueiredo. Daily use may increase the risk of allergic reaction and internal bleeding. "There really needs to be a conversation between clinicians and patients about both the risks and benefits. These studies and our results really add to that conversation."

Source: Eurekalert

Citations   close

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Colleen Fleiss. (2021, April 03). Low-dose Aspirin Linked to Lower Colorectal Cancer Death Risk. Medindia. Retrieved on May 17, 2022 from https://www.medindia.net/news/healthwatch/low-dose-aspirin-linked-to-lower-colorectal-cancer-death-risk-200652-1.htm.

  • MLA

    Colleen Fleiss. "Low-dose Aspirin Linked to Lower Colorectal Cancer Death Risk". Medindia. May 17, 2022. <https://www.medindia.net/news/healthwatch/low-dose-aspirin-linked-to-lower-colorectal-cancer-death-risk-200652-1.htm>.

  • Chicago

    Colleen Fleiss. "Low-dose Aspirin Linked to Lower Colorectal Cancer Death Risk". Medindia. https://www.medindia.net/news/healthwatch/low-dose-aspirin-linked-to-lower-colorectal-cancer-death-risk-200652-1.htm. (accessed May 17, 2022).

  • Harvard

    Colleen Fleiss. 2021. Low-dose Aspirin Linked to Lower Colorectal Cancer Death Risk. Medindia, viewed May 17, 2022, https://www.medindia.net/news/healthwatch/low-dose-aspirin-linked-to-lower-colorectal-cancer-death-risk-200652-1.htm.

Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Hypertension Day 2022 - Measure Blood Pressure Accurately, Control It, Live Longer!
Drinking This Popular Beverage May Drop Dementia Risk
Worst Mistakes Parents Make When Talking to Kids
View all
Recommended Reading
News Archive
Date
Category
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Cancer and Homeopathy Colo-rectal cancer - Management Colorectal Cancer Chemotherapy Chemotherapy Drugs Cancer Facts Death Facts Cancer Tattoos A Body Art Bereavement 

Most Popular on Medindia

Drug Side Effects Calculator Color Blindness Calculator Calculate Ideal Weight for Infants Blood Pressure Calculator Accident and Trauma Care Noscaphene (Noscapine) Loram (2 mg) (Lorazepam) Find a Doctor Turmeric Powder - Health Benefits, Uses & Side Effects Daily Calorie Requirements

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2022

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
open close
CONSULT A DOCTOR